When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MYOV - Baird highlights biopharma with catalysts to come and 100% upside
Myovant Sciences Ltd.
Baird notes that clinical-stage biopharmaceutical firm Myovant Sciences (MYOV+3.2%) submitted its New Drug Application for relugolix in patients with advanced prostate cancer - and says that more catalysts can drive a continued share-price rebound during the pandemic.
More news on: Myovant Sciences Ltd., Healthcare stocks news, Notable Calls, Stocks on the move,